ATLAS (Adjuvant Tamoxifen, Longer Against Shorter): international randomized trial of 10 versus 5 years of adjuvant tamoxifen among 11500 women - preliminary results. - Peto,R.; Davies,C. (Breast Cancer Res Treat, 2007)